|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
KR100477070B1
(ko)
|
1994-03-25 |
2006-04-21 |
이소테크니카 인코포레이티드 |
중수소화작용에의한의약품의효능강화법
|
|
US5919785A
(en)
|
1996-04-03 |
1999-07-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US20030158186A1
(en)
|
2001-12-21 |
2003-08-21 |
Fady Malik |
Compositions and methods for treating heart failure
|
|
US7399866B2
(en)
|
2003-01-14 |
2008-07-15 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
WO2004086865A1
(en)
|
2003-03-27 |
2004-10-14 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
US20070155713A1
(en)
|
2003-04-21 |
2007-07-05 |
Rena Nishizawa |
Nitrogen-containing heterocyclic compounds and use thereof
|
|
US7507735B2
(en)
|
2004-06-17 |
2009-03-24 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
MX2007006230A
(es)
|
2004-11-30 |
2007-07-25 |
Amgen Inc |
Quinolinas y analogos de quinazolinas y su uso como medicamentos para tratar cancer.
|
|
US20060173183A1
(en)
|
2004-12-31 |
2006-08-03 |
Alantos Pharmaceuticals, Inc., |
Multicyclic bis-amide MMP inhibitors
|
|
TW200718692A
(en)
|
2005-04-22 |
2007-05-16 |
Wyeth Corp |
Dihydrobenzofuran derivatives and uses thereof
|
|
WO2007078815A2
(en)
|
2005-12-16 |
2007-07-12 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
|
RU2318818C1
(ru)
|
2006-04-12 |
2008-03-10 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты)
|
|
SA08290245B1
(ar)
|
2007-04-23 |
2012-02-12 |
استرازينيكا ايه بي |
مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
|
|
US20090192168A1
(en)
|
2008-01-04 |
2009-07-30 |
Alex Muci |
Compounds, Compositions and Methods
|
|
ES2459468T3
(es)
|
2009-05-15 |
2014-05-09 |
Novartis Ag |
Arilpiridinas como inhibidores de aldosterona sintasa
|
|
US8592426B2
(en)
|
2011-01-24 |
2013-11-26 |
Hoffmann—La Roche Inc. |
Aryl-benzocycloalkyl amide derivatives
|
|
US8759380B2
(en)
|
2011-04-22 |
2014-06-24 |
Cytokinetics, Inc. |
Certain heterocycles, compositions thereof, and methods for their use
|
|
TWI576347B
(zh)
|
2012-01-20 |
2017-04-01 |
艾克泰聯製藥有限公司 |
作為p2x受體拮抗劑之雜環醯胺衍生物
|
|
SMT202000071T1
(it)
|
2013-06-21 |
2020-03-13 |
Myokardia Inc |
Composti di pirimidinadione contro le condizioni cardiache
|
|
US9199945B2
(en)
|
2013-06-21 |
2015-12-01 |
MyoKardia, Inc. |
Cycloalkyl-substituted pyrimidinedione compounds
|
|
US9663516B2
(en)
|
2014-12-18 |
2017-05-30 |
MyoKardia, Inc. |
Bicyclic-pyrimidinedione compounds
|
|
CN104539229A
(zh)
|
2014-12-26 |
2015-04-22 |
金海新源电气江苏有限公司 |
一种太阳能光伏支架
|
|
SG11201705928XA
(en)
|
2015-01-22 |
2017-08-30 |
Myokardia Inc |
4-methylsulfonyl-substituted piperidine urea compounds for the treatment of dilated cardiomyopathy (dcm)
|
|
CN108430997B
(zh)
|
2015-12-17 |
2021-06-04 |
先正达参股股份有限公司 |
杀微生物的噁二唑衍生物
|
|
US20190364899A1
(en)
|
2015-12-18 |
2019-12-05 |
Syngenta Participations Ag |
Microbiocidal oxadiazole derivatives
|
|
CA3022432A1
(en)
|
2016-04-29 |
2017-11-02 |
Board Of Regents, The University Of Texas System |
Sigma receptor binders
|
|
EP3475275B1
(en)
|
2016-06-23 |
2024-04-10 |
Merck Sharp & Dohme LLC |
3-aryl and heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors
|
|
SI3519416T1
(sl)
|
2016-09-27 |
2021-08-31 |
Merck Sharp & Dohme Corp. |
Derivati kromana, izokromana in dihidroizobenzofurana kot mGluR2-negativni alosterični modulatorji, sestavki in njihova uporaba
|
|
WO2018089433A1
(en)
|
2016-11-08 |
2018-05-17 |
Navitor Pharmaceuticals, Inc. |
PHENYL mTORC INHIBITORS AND USES THEREOF
|
|
US20200000822A1
(en)
|
2017-02-23 |
2020-01-02 |
Board Of Regents, The University Of Texas System |
Methods of treatment for cancer, sterol homeostasis, and neurological diseases
|
|
IL322175A
(en)
|
2017-08-04 |
2025-09-01 |
Myokardia Inc |
Treatment of hypertrophic cardiomyopathy (HCM) with pyrimidinedione compounds
|
|
SG11202006296YA
(en)
|
2018-01-19 |
2020-08-28 |
Cytokinetics Inc |
Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
|
|
CR20200464A
(es)
|
2018-03-08 |
2021-04-14 |
Incyte Corp |
Compuestos diólicos de aminopirazina como inhibidores de pi3k-y
|
|
US10710994B2
(en)
|
2018-03-19 |
2020-07-14 |
Genentech, Inc. |
Oxadiazole transient receptor potential channel inhibitors
|
|
EP3814343B1
(en)
|
2018-06-26 |
2023-01-11 |
Cytokinetics, Inc. |
Cardiac sarcomere inhibitors
|
|
JP7438148B2
(ja)
|
2018-06-26 |
2024-02-26 |
サイトキネティックス, インコーポレイテッド |
心臓サルコメア阻害剤
|
|
MA53491A
(fr)
|
2018-08-31 |
2021-09-15 |
Cytokinetics Inc |
Inhibiteurs de sarcomes cardiaques
|
|
US10981905B2
(en)
|
2018-08-31 |
2021-04-20 |
Xenon Pharmaceuticals Inc. |
Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents
|
|
IL325304A
(en)
|
2018-10-29 |
2026-02-01 |
Myokardia Inc |
4-Tetrahydropyran-4-yl-6-fluoro-7-phenyl-8,7,6,5-tetrahydro-h1-pyrido[3,2-d]pyrimidine-2,4-dione
|
|
LT3999180T
(lt)
|
2019-07-17 |
2024-08-26 |
Cytokinetics, Inc. |
(r)-n-(5-(5-etil-1,2,4-oksadiazol-3-il)-2,3-dihidro-1h-inden-1-il)-1-metil-1h-pirazol-4-karboksamido polimorfai
|
|
WO2021011808A1
(en)
|
2019-07-17 |
2021-01-21 |
Cytokinetics, Inc. |
Cardiac sarcomere inhibitor oral formulations
|
|
CA3157629A1
(en)
|
2019-11-10 |
2021-05-14 |
MyoKardia, Inc. |
Methods of treatment with myosin modulator
|
|
KR20230079053A
(ko)
|
2020-08-28 |
2023-06-05 |
미요카디아, 인크. |
미오신 조절제를 이용한 치료 방법
|
|
CN114456163B
(zh)
|
2020-11-09 |
2023-08-11 |
江苏恒瑞医药股份有限公司 |
四氢吡啶并嘧啶二酮类衍生物、其制备方法及其在医药上的应用
|
|
CN114516843B
(zh)
|
2020-11-19 |
2024-10-22 |
江苏恒瑞医药股份有限公司 |
嘧啶二酮类衍生物、其制备方法及其在医药上的应用
|
|
EP4249474A4
(en)
|
2020-11-20 |
2024-04-17 |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
Triazine dione derivative, preparation method therefor and application thereof in medicine
|
|
CN116507621B
(zh)
|
2020-11-24 |
2025-10-17 |
江苏恒瑞医药股份有限公司 |
嘧啶二酮类衍生物、其制备方法及其在医药上的应用
|
|
CN114539229B
(zh)
|
2020-11-24 |
2024-10-22 |
江苏恒瑞医药股份有限公司 |
嘧啶二酮类衍生物、其制备方法及其在医药上的应用
|
|
CN114539257B
(zh)
|
2020-11-24 |
2023-08-11 |
江苏恒瑞医药股份有限公司 |
嘧啶二酮类螺环衍生物、其制备方法及其在医药上的应用
|
|
AR125588A1
(es)
|
2021-03-04 |
2023-08-02 |
Lilly Co Eli |
Compuestos inhibidores de fgfr3
|
|
KR20240015622A
(ko)
|
2021-03-04 |
2024-02-05 |
싸이토키네틱스, 인코포레이티드 |
심장 근절 억제제
|
|
CN119998292A
(zh)
|
2022-09-02 |
2025-05-13 |
赛特凯恩蒂克公司 |
5-(3,4-二氟苄基)-8-((1r,4r)-4-甲基环己基)-6,9-二氧代基-2,5,8-三氮杂螺[3.5]壬烷-2-甲醛的结晶形式
|